About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

NCT00301431·59 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Wyeth is now a wholly owned subsidiary of Pfizer

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Fibromyalgia according to 1990 American College of Rheumatology (ACR) criteria

You may not be if

Other painful conditions that may make results difficult to interpret.
Treatment with other drugs for fibromyalgia with 14 days of study start or during the study.

The record

StatusTerminated

PhasePhase 2–3

Taking part1,050

StartedAug 2006

UpdatedDec 5, 2007

Conditions

Where59

Huntsville, Alabama, United States
Mobile, Alabama, United States
Phoenix, Arizona, United States